Global Genitourinary Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Genitourinary Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Genitourinary Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Genitourinary Drugs by Country/Region, 2017, 2022 & 2028

2.2 Genitourinary Drugs Segment by Type

2.2.1 Urologicals

2.2.2 Hormonal Therapy

2.2.3 Gynecological

2.2.4 Anti-infectives

2.3 Genitourinary Drugs Sales by Type

2.3.1 Global Genitourinary Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Genitourinary Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Genitourinary Drugs Sale Price by Type (2017-2022)

2.4 Genitourinary Drugs Segment by Application

2.4.1 Prostate Cancer

2.4.2 Ovarian Cancer

2.4.3 Bladder Cancer

2.4.4 Cervical Cancer

2.4.5 Renal Cancer

2.4.6 Erectile Dysfunction

2.4.7 Urinary Tract Infections

2.4.8 Urinary Incontinence & Overactive Bladder

2.4.9 Sexually Transmitted Diseases

2.5 Genitourinary Drugs Sales by Application

2.5.1 Global Genitourinary Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Genitourinary Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Genitourinary Drugs Sale Price by Application (2017-2022)

3 Global Genitourinary Drugs by Company

3.1 Global Genitourinary Drugs Breakdown Data by Company

3.1.1 Global Genitourinary Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Genitourinary Drugs Sales Market Share by Company (2020-2022)

3.2 Global Genitourinary Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Genitourinary Drugs Revenue by Company (2020-2022)

3.2.2 Global Genitourinary Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Genitourinary Drugs Sale Price by Company

3.4 Key Manufacturers Genitourinary Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Genitourinary Drugs Product Location Distribution

3.4.2 Players Genitourinary Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Genitourinary Drugs by Geographic Region

4.1 World Historic Genitourinary Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Genitourinary Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Genitourinary Drugs Annual Revenue by Geographic Region

4.2 World Historic Genitourinary Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Genitourinary Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Genitourinary Drugs Annual Revenue by Country/Region

4.3 Americas Genitourinary Drugs Sales Growth

4.4 APAC Genitourinary Drugs Sales Growth

4.5 Europe Genitourinary Drugs Sales Growth

4.6 Middle East & Africa Genitourinary Drugs Sales Growth

5 Americas

5.1 Americas Genitourinary Drugs Sales by Country

5.1.1 Americas Genitourinary Drugs Sales by Country (2017-2022)

5.1.2 Americas Genitourinary Drugs Revenue by Country (2017-2022)

5.2 Americas Genitourinary Drugs Sales by Type

5.3 Americas Genitourinary Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Genitourinary Drugs Sales by Region

6.1.1 APAC Genitourinary Drugs Sales by Region (2017-2022)

6.1.2 APAC Genitourinary Drugs Revenue by Region (2017-2022)

6.2 APAC Genitourinary Drugs Sales by Type

6.3 APAC Genitourinary Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Genitourinary Drugs by Country

7.1.1 Europe Genitourinary Drugs Sales by Country (2017-2022)

7.1.2 Europe Genitourinary Drugs Revenue by Country (2017-2022)

7.2 Europe Genitourinary Drugs Sales by Type

7.3 Europe Genitourinary Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Genitourinary Drugs by Country

8.1.1 Middle East & Africa Genitourinary Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Genitourinary Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Genitourinary Drugs Sales by Type

8.3 Middle East & Africa Genitourinary Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Genitourinary Drugs

10.3 Manufacturing Process Analysis of Genitourinary Drugs

10.4 Industry Chain Structure of Genitourinary Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Genitourinary Drugs Distributors

11.3 Genitourinary Drugs Customer

12 World Forecast Review for Genitourinary Drugs by Geographic Region

12.1 Global Genitourinary Drugs Market Size Forecast by Region

12.1.1 Global Genitourinary Drugs Forecast by Region (2023-2028)

12.1.2 Global Genitourinary Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Genitourinary Drugs Forecast by Type

12.7 Global Genitourinary Drugs Forecast by Application

13 Key Players Analysis

13.1 Novartis AG

13.1.1 Novartis AG Company Information

13.1.2 Novartis AG Genitourinary Drugs Product Offered

13.1.3 Novartis AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis AG Main Business Overview

13.1.5 Novartis AG Latest Developments

14 Research Findings and Conclusion

Table 1. Genitourinary Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Genitourinary Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Urologicals

Table 4. Major Players of Hormonal Therapy

Table 5. Major Players of Gynecological

Table 6. Major Players of Anti-infectives

Table 7. Global Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 8. Global Genitourinary Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Genitourinary Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Genitourinary Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Genitourinary Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 13. Global Genitourinary Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Genitourinary Drugs Revenue by Application (2017-2022)

Table 15. Global Genitourinary Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Genitourinary Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Genitourinary Drugs Sales by Company (2020-2022) & (K Units)

Table 18. Global Genitourinary Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Genitourinary Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Genitourinary Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Genitourinary Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Genitourinary Drugs Producing Area Distribution and Sales Area

Table 23. Players Genitourinary Drugs Products Offered

Table 24. Genitourinary Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Genitourinary Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Genitourinary Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Genitourinary Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Genitourinary Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Genitourinary Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Genitourinary Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Genitourinary Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Genitourinary Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 36. Americas Genitourinary Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Genitourinary Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Genitourinary Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 40. Americas Genitourinary Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 42. Americas Genitourinary Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Genitourinary Drugs Sales by Region (2017-2022) & (K Units)

Table 44. APAC Genitourinary Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Genitourinary Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Genitourinary Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 48. APAC Genitourinary Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 50. APAC Genitourinary Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 52. Europe Genitourinary Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Genitourinary Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Genitourinary Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 56. Europe Genitourinary Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 58. Europe Genitourinary Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Genitourinary Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Genitourinary Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Genitourinary Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Genitourinary Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Genitourinary Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Genitourinary Drugs

Table 68. Key Market Challenges & Risks of Genitourinary Drugs

Table 69. Key Industry Trends of Genitourinary Drugs

Table 70. Genitourinary Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Genitourinary Drugs Distributors List

Table 73. Genitourinary Drugs Customer List

Table 74. Global Genitourinary Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Genitourinary Drugs Sales Market Forecast by Region

Table 76. Global Genitourinary Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Genitourinary Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Genitourinary Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Genitourinary Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Genitourinary Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Genitourinary Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Genitourinary Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Genitourinary Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Genitourinary Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Genitourinary Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Genitourinary Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Genitourinary Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Genitourinary Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Genitourinary Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Genitourinary Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Genitourinary Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Genitourinary Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Genitourinary Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Novartis AG Basic Information, Genitourinary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Novartis AG Genitourinary Drugs Product Offered

Table 96. Novartis AG Genitourinary Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Novartis AG Main Business

Table 98. Novartis AG Latest Developments

Table 99. Genentech Basic Information, Genitourinary Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Genentech Genitourinary Drugs Product Offered

Table 101. Genentech Genitourinary Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Genentech Main Business

Table 103. Genentech Latest Developments

List of Figures

Figure 1. Picture of Genitourinary Drugs

Figure 2. Genitourinary Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Genitourinary Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Genitourinary Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Genitourinary Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Urologicals

Figure 10. Product Picture of Hormonal Therapy

Figure 11. Product Picture of Gynecological

Figure 12. Product Picture of Anti-infectives

Figure 13. Global Genitourinary Drugs Sales Market Share by Type in 2021

Figure 14. Global Genitourinary Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Genitourinary Drugs Consumed in Prostate Cancer

Figure 16. Global Genitourinary Drugs Market: Prostate Cancer (2017-2022) & (K Units)

Figure 17. Genitourinary Drugs Consumed in Ovarian Cancer

Figure 18. Global Genitourinary Drugs Market: Ovarian Cancer (2017-2022) & (K Units)

Figure 19. Genitourinary Drugs Consumed in Bladder Cancer

Figure 20. Global Genitourinary Drugs Market: Bladder Cancer (2017-2022) & (K Units)

Figure 21. Genitourinary Drugs Consumed in Cervical Cancer

Figure 22. Global Genitourinary Drugs Market: Cervical Cancer (2017-2022) & (K Units)

Figure 23. Genitourinary Drugs Consumed in Renal Cancer

Figure 24. Global Genitourinary Drugs Market: Renal Cancer (2017-2022) & (K Units)

Figure 25. Genitourinary Drugs Consumed in Erectile Dysfunction

Figure 26. Global Genitourinary Drugs Market: Erectile Dysfunction (2017-2022) & (K Units)

Figure 27. Genitourinary Drugs Consumed in Urinary Tract Infections

Figure 28. Global Genitourinary Drugs Market: Urinary Tract Infections (2017-2022) & (K Units)

Figure 29. Genitourinary Drugs Consumed in Urinary Incontinence & Overactive Bladder

Figure 30. Global Genitourinary Drugs Market: Urinary Incontinence & Overactive Bladder (2017-2022) & (K Units)

Figure 31. Genitourinary Drugs Consumed in Sexually Transmitted Diseases

Figure 32. Global Genitourinary Drugs Market: Sexually Transmitted Diseases (2017-2022) & (K Units)

Figure 33. Global Genitourinary Drugs Sales Market Share by Application (2017-2022)

Figure 34. Global Genitourinary Drugs Revenue Market Share by Application in 2021

Figure 35. Genitourinary Drugs Revenue Market by Company in 2021 ($ Million)

Figure 36. Global Genitourinary Drugs Revenue Market Share by Company in 2021

Figure 37. Global Genitourinary Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 38. Global Genitourinary Drugs Revenue Market Share by Geographic Region in 2021

Figure 39. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)

Figure 40. Global Genitourinary Drugs Revenue Market Share by Country/Region in 2021

Figure 41. Americas Genitourinary Drugs Sales 2017-2022 (K Units)

Figure 42. Americas Genitourinary Drugs Revenue 2017-2022 ($ Millions)

Figure 43. APAC Genitourinary Drugs Sales 2017-2022 (K Units)

Figure 44. APAC Genitourinary Drugs Revenue 2017-2022 ($ Millions)

Figure 45. Europe Genitourinary Drugs Sales 2017-2022 (K Units)

Figure 46. Europe Genitourinary Drugs Revenue 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Genitourinary Drugs Sales 2017-2022 (K Units)

Figure 48. Middle East & Africa Genitourinary Drugs Revenue 2017-2022 ($ Millions)

Figure 49. Americas Genitourinary Drugs Sales Market Share by Country in 2021

Figure 50. Americas Genitourinary Drugs Revenue Market Share by Country in 2021

Figure 51. United States Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Canada Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Mexico Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Brazil Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. APAC Genitourinary Drugs Sales Market Share by Region in 2021

Figure 56. APAC Genitourinary Drugs Revenue Market Share by Regions in 2021

Figure 57. China Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Japan Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Korea Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Southeast Asia Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. India Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Australia Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Europe Genitourinary Drugs Sales Market Share by Country in 2021

Figure 64. Europe Genitourinary Drugs Revenue Market Share by Country in 2021

Figure 65. Germany Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. France Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. UK Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Italy Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. Russia Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Middle East & Africa Genitourinary Drugs Sales Market Share by Country in 2021

Figure 71. Middle East & Africa Genitourinary Drugs Revenue Market Share by Country in 2021

Figure 72. Egypt Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 73. South Africa Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 74. Israel Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 75. Turkey Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 76. GCC Country Genitourinary Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 77. Manufacturing Cost Structure Analysis of Genitourinary Drugs in 2021

Figure 78. Manufacturing Process Analysis of Genitourinary Drugs

Figure 79. Industry Chain Structure of Genitourinary Drugs

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles